That belief is not only falseits harmful
Retatrutide edges out Tirzepatide on raw weight loss numbers, posting 24.2 percent average reduction in Phase 2 trials versus 20.9 percent for Tirzepatide at peak dose
Although many patients experience weight loss as a secondary benefit, it is important to note that Ozempic is not licensed for weight management in the UK
The alternative name exists for regulatory compliance, allowing the company to sell the compound as a research chemical rather than a pharmaceutical product
Yes, this is worth considering, especially if you snore loudly, wake gasping, have morning headaches, or feel excessively sleepy during the day
Most importantly, consult with a qualified healthcare provider before considering any peptide or supplement